For Research Use Only · Not for human or veterinary consumptionBatch-specific analytical results · Review the matching COAAvailable certificates by product, strength and laboratory lotUS-based operations · Discreet laboratory packagingFor Research Use Only · Not for human or veterinary consumptionBatch-specific analytical results · Review the matching COAAvailable certificates by product, strength and laboratory lotUS-based operations · Discreet laboratory packaging
Veytralis TR research vial, 10mg
Tested-lot report · COA Research use only

Veytralis TR

Mass

$75.00

$75.00/vial

Quantity
1
Quantity pricing

Analytical documentation

10mg · Report 2610AFL1842.6293 available via COA

Estimated arrival · 2–8 calendar days from ordering

Estimated delivery window · shipping rates shown at checkout

Overnight and two-day options

Select DHL Ground, 2Day or Next Day at checkout

Secure encrypted checkout

Veytralis (TR) is supplied for laboratory investigation and analytical work. Nominal amount: 10mg. Ingredient identity: Tirzepatide. Research use only; not for human, animal, veterinary or clinical use. Qualified researchers 21+ only.

This product is supplied strictly for in vitro laboratory research. Not for human, animal, veterinary, therapeutic, diagnostic or clinical use. By purchasing, you confirm you are a qualified researcher aged 21 or older.

Research reagent identity

For in vitro laboratory research use only.

Catalog name
Veytralis TR
Ingredient identity
Tirzepatide
Selected strength
10mg
Certificate ID
2610AFL1842.6293
Tested-lot purity result
99.68%
Laboratory lot
1926-99010
Testing laboratory
Accurate Test Labs
Source organization
South Florida Stem Cells
Date tested
October 7, 2026

Results describe the tested laboratory lot in the published report. Archived or tested-lot results do not guarantee the lot currently shipping.

Explore the catalog

Related research compounds

Box and quantity options

Box

Build a Box

Choose four products at their selected catalog prices. No subscription.

Build your box
20%

Bundle pricing

2 vials 5% · 3 vials 10% · 5 vials 15% · 10 vials 20% off per vial.

Browse catalog

Reported test results

Published batch results

Results apply only to the tested laboratory lot and do not confirm the lot that will ship. Request current lot documentation where needed.

Certificate of analysis · 2610AFL1842.6293

99.68%

Reported purity

Lot
1926-99010
Date tested
October 7, 2026
Labeled
10mg
Measured
15.62mg/unit (as reported)

Certificate summary · 10mg

Lot-specific
PurityReported by laboratory
99.68%
Quantity resultMeasured
15.62mg/unit (as reported)
Labeled amountNominal
10mg
IdentityCompound tested
Tirzepatide
Laboratory lotLab identifier
1926-99010
Date testedAs printed on report
October 7, 2026
Identity resultAs reported
Confirmed (reported)

Published certificate history

Open any lot's certificate. Each record applies only to its exact strength and lot.

Veytralis TR 20mg

Certificate 2610AFL1842.6296

Tested-lot report · shipped lot not confirmed

99.9%

Labeled
20mg
Measured
22.82mg/unit (as reported)
Lot
1926-99017
Date tested
October 8, 2026

Veytralis TR 60mg

Certificate 2610AFL1842.6292

Tested-lot report · shipped lot not confirmed

99.66%

Labeled
60mg
Measured
66.59mg/unit (as reported)
Lot
1926-99009
Date tested
October 8, 2026

Veytralis TR 10mg

Certificate 2610AFL1842.6293

Tested-lot report · shipped lot not confirmed

99.68%

Labeled
10mg
Measured
15.62mg/unit (as reported)
Lot
1926-99010
Date tested
October 7, 2026

Veytralis TR 20mg

Certificate KNJG-C5FC

Tested-lot report · shipped lot not confirmed

99.969%

Labeled
20mg
Measured
20.422mg measured (as reported)
Lot
1926-9900
Report published
September 1, 2026

Veytralis TR 30mg

Certificate L2KQ-WXC2

Tested-lot report · shipped lot not confirmed

99.925%

Labeled
30mg
Measured
30.05mg measured (as reported)
Lot
1926-9902
Report published
September 1, 2026

Veytralis TR 30mg

Certificate 2607AFL1224.4281

Tested-lot report · shipped lot not confirmed

99.93% total

Labeled
30mg
Measured
31.05mg/unit (as reported)
Lot
1926-9712
Date tested
July 28, 2026

Veytralis TR 20mg

Certificate 2607AFL1193.4181

Tested-lot report · shipped lot not confirmed

99.793%

Labeled
20mg
Measured
23.28mg/unit
Lot
1926-9632
Date tested
July 22, 2026

Veytralis TR 60mg

Certificate 2607AFL1160.4075

Tested-lot report · shipped lot not confirmed

99.845%

Labeled
60mg
Measured
63.16mg/unit (as reported)
Lot
1926-9568
Date tested
July 21, 2026

Veytralis TR 20mg

Certificate 2602AFL0253.0906

Tested-lot report · shipped lot not confirmed

99.884%

Labeled
20mg
Measured
23.6mg/unit
Lot
1926-009
Date tested
March 2, 2026

Technical specifications

Compound information

Selected specification

Veytralis TR

Nominal amount
10mg
Commerce SKU
VYT-TZ-10MG
Availability
In stock

Technical specifications

Ingredient identity: Tirzepatide. Classification: peptide research compound. Nominal amount is specified by the selected variation; it is not a measured batch result.

Batch documentation

Review the certificate for the exact ingredient, strength and laboratory lot. Purity and measured quantity apply only to that tested lot. Archived certificates do not confirm the lot that will ship; request current lot documentation.

Research restrictions

For in vitro laboratory research only. Not for human, animal, veterinary, clinical or diagnostic use. Qualified researchers aged 21 or older only.

Important research notice

Not for human, animal or veterinary use. This product is offered solely for laboratory research and analytical use. It is not intended for human or veterinary use, clinical use, diagnosis, treatment, cure, or prevention of disease. No dosing, administration, or therapeutic claims are made in this listing.

Refer to applicable product documentation, certificate of analysis, lot information, and applicable laws and regulations before use in a research setting.

By purchasing, you confirm you are a qualified researcher aged 21 or older.